General Oncology News
The American Society of Clinical Oncology has selected "Progress in Treating Rare Cancers" as the 2019 Advance of the Year.
Obesity in childhood and adolescence may be related to the disproportionate rise in certain obesity-related cancers in younger adults, according to authors.
Immune checkpoint therapy with programmed cell death-1 (PD-1) inhibitors was linked to activation of latent Mycobacterium tuberculosis (Mtb) infection in 2 patients.
Researchers propose a way to determine the long-term benefit of immune checkpoint inhibitors that differs from the approach in the ASCO Value Framework.
Administration of vaccines via the unconventional intravenous route conferred greater antitumor activity in mice than the traditional subcutaneous route.
This study provides evidence that birinapant could enhance sensitivity to TNF, effectively boosting the activity of CAR-T therapy in solid tumors.
Illumina's TruSight Oncology 500 next-generation sequencing assay has been assigned a breakthrough device status by the FDA.
The perception that there are high surgical complication rates with CS/HIPEC in peritoneal metastasis may be inaccurate.
A study found no significant association between patient sex and efficacy of immunotherapy in patients with advanced cancers, contradicting previous evidence.
A single definition of TMB as a predictor of survival benefit from immune checkpoint inhibitors across cancer types is not feasible, according to authors.
Immune checkpoint blockade combined with chemotherapy may sensitize "cold" tumors to immunotherapy and lead to enhanced responses.
The spend on medical marketing in the United States has dramatically grown over a 20-year span, but drug marketing as a proportion of total US drug spending decreased.
The findings suggest that changes in genetic testing criteria are warranted.
A report highlights the current gap in the utilization of radiotherapy in Europe and outlines an action plan as a solution.
Disruptions in barrier integrity, use of corticosteroids, and use of intravenous antibiotics prior to chemotherapy may increase risk of febrile neutropenia.
To make informed treatment decisions, the affect a drug has on a patient's quality of life must be considered, investigators argued.
Integration of liquid biopsies will require understanding of their advantages and limitations.
A pleural adherence score derived from thoracic ultrasound at 24 hours post-talc administration is predictive of long-term pleurodesis success in patients with symptomatic malignant pleural effusion.
Health experts from around the world shared research at the 2018 World Cancer Congress. We recapped 5 key findings presented at the event.
A recent Lancet Oncology Commission laid out why oncology and palliative care should be integrated and how to achieve successful integration despite barriers.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- No Benefit Seen From HSCT in Hypodiploid B-ALL
- Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
- Opinion: Understanding the FDA's Take on Cannabidiol
- High IDO1 Tumor Expression May Predict Poor Overall Survival in Patients With Anal Cancer
- Ambient Benzene Exposure and Risk of Hematologic Malignancies